The DOI matches its Crossref record; the references it cites are not checked yet.
In Vitro Activity of E1210, a Novel Antifungal, against Clinically Important Yeasts and Molds
Open accessAbstract
E1210 is a new antifungal compound with a novel mechanism of action and broad spectrum of antifungal activity. We investigated the in vitro antifungal activities of E1210 compared to those of fluconazole, itraconazole, voriconazole, amphotericin B, and micafungin against clinical fungal isolates. E1210 showed potent activities against most Candida spp. (MIC 90 of ≤0.008 to 0.06 μg/ml), except for Candida krusei (MICs of 2 to >32 μg/ml). E1210 showed equally potent activities against fluconazole-resistant and fluconazole-susceptible Candida strains. E1210 also had potent activities against various filamentous fungi, including Aspergillus fumigatus (MIC 90 of 0.13 μg/ml). E1210 was also active against Fusarium solani and some black molds. Of note, E1210 showed the greatest activities against Pseudallescheria boydii (MICs of 0.03 to 0.13 μg/ml), Scedosporium prolificans (MIC of 0.03 μg/ml), and Paecilomyces lilacinus (MICs of 0.06 μg/ml) among the compounds tested. The antifungal action of E1210 was fungistatic, but E1210 showed no trailing growth of Candida albicans , which has often been observed with fluconazole. In a cytotoxicity assay using human HK-2 cells, E1210 showed toxicity as low as that of fluconazole. Based on these results, E1210 is likely to be a promising antifungal agent for the treatment of invasive fungal infections.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Low minimal inhibitory concentrations (MICs) of this new antifungal were found against C. albicans, C. tropicalis, C. glabrata, C. parapsilosis, C. lusitaniae, C. kefyr, (Miyazaki et al., 2011; Pfaller et al., 2019), and also against multidrug-resistant C. auris (Hager et al., 2018a), and echinocandin-resistant C. glabrata (Pfaller et al., 2019).”
From Fungal Cell Wall: Emerging Antifungals and Drug Resistance. (2019) · cites this paper as Miyazaki et al., 2011
In the citing paper
“Regarding in vitro activity against molds, low MICs against Aspergillus species from the Section Fumigati, Flavi, Terrei, and Nigri (Miyazaki et al., 2011; Pfaller et al., 2019), Purpureocillium lilacinum, Cladosporium species, Phialophora species, Rhinocladiella aquaspersa, Fonsecaea pedrosoi (Miyazaki et al., 2011), Scedosporium apiospermum, and Scedosporium aurantiacum (Castanheira et al., 2012”
From Fungal Cell Wall: Emerging Antifungals and Drug Resistance. (2019) · cites this paper as Miyazaki et al., 2011
In the citing paper
“MGX inhibits the conserved fungal glycosylphosphatidylinositol (GPI)-anchored wall transfer protein 1 (Gwt1) (13, 14).”
From Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris : Results from a Phase 2 Trial (2023) · cites this paper as [13]
In the citing paper
“FMGX improved survival over anidulafungin, an echinocandin, in a disseminated C. auris infection model in immunocompromised mice (13).”
From Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris : Results from a Phase 2 Trial (2023) · cites this paper as [13]
In the citing paper
“Fosmanogepix possesses broad in vitro activity against many genera of fungi: Candida (excluding C. krusei), Trichosporon, Coccidioides, Cryptococcus, Aspergillus (A. fumigatus, A. flavus, A. niger), as well as AmB-resistant strains of Fusarium and Scedosporium (Fig. 1) [51, 53–55].”
From Investigational Agents for the Treatment of Resistant Yeasts and Molds (2021) · cites this paper as [51]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 23 · Cited by 200
Research works printed but not linked: 6
- Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi: approved standard, 2nd ed. CLSI document M38-A2. CLSI, Wayne, PA.
- HataK. HoriiT. MiyazakiM. WatanabeN.. 2010. Abstr. 50th Intersci. Conf. Antimicrob. Agents Chemother., abstr. F1-842.
- HoriiT. OkuboM. MiyazakiM. HataK. WatanabeN.. 2010. Abstr. 50th Intersci. Conf. Antimicrob. Agents Chemother., abstr. F1-843.
- OkuboM. ToritsukaN. HoriiT. HataK. SonodaJ.. 2010. Abstr. 50th Intersci. Conf. Antimicrob. Agents Chemother., abstr. F1-844.
- RennieR. SandC. SherburneR.. 1997. Electron microscopic evidence of the effect of LY303366 on Aspergillus fumigatus. Abstr. 13th Congr. Int. Soc. Hum. Animal Mycol., abstr. P451.
- WatanabeN. MiyazakiM. HoriiT. HataK.. 2010. Abstr. 50th Intersci. Conf. Antimicrob. Agents Chemother., abstr. F1-841.
Metadata
- Authors
- Miyazaki, M., Horii, T., Hata, K., Watanabe, N.-A., Nakamoto, K., Tanaka, K., Shirotori, S., Murai, N., Inoue, S., Matsukura, M., Abe, S., Yoshimatsu, K., & Asada, M.
- Affiliations
- Eisai (Japan) (JP)
- Next Generation Systems Core Function Unit, Eisai Product Creation Systems, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki, Japan
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2011-10
- Volume
- 55
- Issue
- 10
- Pages
- 4652-4658
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC3186989
- OpenAlex
- W2114599108
- Cited by
- 200
- References
- 23
- Citations by year
- 2026: 14 · 2025: 15 · 2024: 21 · 2023: 16 · 2022: 18 · 2021: 16 · 2020: 22 · 2019: 18 · 2018: 16 · 2017: 12 · 2016: 7 · 2015: 4 · 2014: 10 · 2013: 4 · 2012: 3
- FWCI
- 4.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- antifungal agents, Candida, Candida albicans, Candida krusei, Aspergillus fumigatus, Fusarium solani, Pseudallescheria boydii, Scedosporium prolificans, Paecilomyces lilacinus, black mold, fluconazole resistance, invasive fungal infections, fungistatic activity, cytotoxicity, HK-2 cells, minimum inhibitory concentration
- MeSH terms
- Micafungin, Aminopyridines, Amphotericin B, Antifungal Agents, Aspergillus, Candida, Cell Line, Fungi, Fusarium, Humans, Isoxazoles, Microbial Sensitivity Tests, Paecilomyces, Pseudallescheria, Pyrimidines, Triazoles, Yeasts, Fluconazole, Itraconazole, Scedosporium, Echinocandins, Lipopeptides, Voriconazole
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In Vitro Activity of E1210, a Novel Antifungal, against Clinically Important Yeasts and Molds. https://app.cochat.ai/papers/10.1128/aac.00291-11
- The paper
- Miyazaki, M., Horii, T., Hata, K., Watanabe, N.-A., Nakamoto, K., Tanaka, K., Shirotori, S., Murai, N., Inoue, S., Matsukura, M., Abe, S., Yoshimatsu, K., & Asada, M. (2011). In Vitro Activity of E1210, a Novel Antifungal, against Clinically Important Yeasts and Molds. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00291-11
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.